Butantan announces first home-grown Brazilian vaccine and will start testing it in humans

São Paulo governor João Doria foresees 40 million doses of Butanvac available in July.

RIO DE JANEIRO, BRAZIL - The Butantan Institute announced on Friday, March 26th, its first domestically manufactured vaccine, Butanvac, developed by the São Paulo state-owned entity, which is awaiting authorization from regulatory bodies to begin immediate testing in humans, according to the governor of São Paulo, João Doria.

"This is a historic announcement for the world. The vaccine is one hundred percent domestic, with promising tests and the result of the work of a 120-year-old institution, which is the largest producer of vaccines in the Southern Hemisphere," said Doria at a press conference at the . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?